에 대한 최신 뉴스 S&P Global (NYSE:SPGI) 주식

S&P GLOBAL INC

S&P Global

S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.

Analyst Color

Analyst Ratings

Tech

BURL

FOXA

NCLH

NVDA

PINS

SNOW

SPGI

UBER

골드만삭스 리서치가 새로운 해를 맞아 대담한 주식 선택과 2025년 시장을 형성할 다섯 가지 투자 테마를 조명했다. 무슨 일이 있었나: 목요일에 공유된 노트에서, 스티븐 크론(Steven Kron)이 이끄는 애널리스트 팀은 &#34;컨빅션 리스트(Conviction List)&#34; - 주목할 만한 투자 아이디어로 구성된 포트폴리오를 재조정했다.

골드만삭스, &#39;컨빅션 리스트&#39;에 3개의 주식 추가 및 2025년 주목해야 할 5가지 시장 동향

April,12,,2023,,Brazil.,In,This,Photo,Illustration,,The,Moody's

Government

News

Markets

General

최근 미국 증권거래위원회(SEC)는 무디스(NYSE:MCO)의 무디스 레이팅스(Moody&#39;s Ratings), S&amp;P 글로벌(NYSE:SPGI)의 S&amp;P 글로벌 레이팅스, 피치 레이팅스(Fitch Ratings, Inc.)를 포함한 6개의 주요 신용평가사들에 대해 전자 통신의 유지 및 보존에 중대한 결함이 있었다며 막대한 벌금을 부과했다. 이들 기관들은 총 4,900만 달러를 초과하는 민사 벌금을 납부하기로 합의했다.

美 SEC는 무디스, S&amp;P 글로벌, 피치 포함 6개사들에 기록 유지 실패로 $4,900만 벌금 부가

office empty ai

Specialty ETFs

ETFs

Real Estate

AMZN

GOOG

GOOGL

SCHH

XLRE

상업용 부동산 업계는 원격 근무와 인플레이션 상승의 영향으로 계속해서 어려움을 겪고 있다. 이자율이 상승하고 다양한 산업 분야에서 사무실 공간을 축소하려는 광범위한 추세로 인해 이 분야는 전례 없는 규모의 빈 사무실 공간에 직면하게 되었다.

기술 부문 인력 감원, 재택근무로 사무실 공실율 19.6% 상승, 1979년 이후 최고 수준

S&P Global Inc

Across the recent three months, 17 analysts have shared their insights on Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $114.65, a high estimate of $145.00, and a low estimate of $85.00. This current average represents a 4.85% decrease from the previous average price target of $120.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1750878071_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Shake Shack's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Ivankoe</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Sara Senatore</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$134.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$145.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Anthony Trainor</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Maintains</td>
<td>Hold</td>
<td>$105.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Jake Bartlett</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>John Ivankoe</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$100.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Brian Vaccaro</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Strong Buy</td>
<td>$140.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$105.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Jake Bartlett</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$131.00</td>
<td>$154.00</td>
</tr>
<tr>
<td>Chris O'Cull</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$97.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Brian Bittner</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$125.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$85.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Alton Stump</td>
<td>Loop Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$127.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Shake Shack. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Shake Shack compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Shake Shack's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Shake Shack's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SHAK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Shake Shack analyst ratings.</a>
<h2>About Shake Shack</h2>
Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water.
<h3>Unraveling the Financial Story of Shake Shack</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Shake Shack's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 10.46%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Shake Shack's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 1.32%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Shake Shack's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.9%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Shake Shack's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.25%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Shake Shack's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.74.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SHAK

A Glimpse Into The Expert Outlook On Shake Shack Through 17 Analysts

TE Connectivity's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) short percent of float has fallen 15.32% since its last report. The company recently reported that it has 4.95 million shares sold short, which is 1.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.2 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>TE Connectivity Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750878060_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for TE Connectivity has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing TE Connectivity's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, TE Connectivity's peer group average for short interest as a percentage of float is 3.42%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

What Does the Market Think About TE Connectivity?

Rambus's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NYSE">RMBS</a>) short percent of float has fallen 10.36% since its last report. The company recently reported that it has 3.41 million shares sold short, which is 4.24% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.15 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Rambus Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750878055_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Rambus has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Rambus's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Rambus's peer group average for short interest as a percentage of float is 9.76%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

RMBS

How Is The Market Feeling About Rambus?

In the current session, Globus Medical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) is trading at $58.35, after a 0.53% decrease. Over the past month, the stock fell by 1.45%, and in the past year, by 15.25%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1750878053_0.png" alt="Past Year Chart" />

<h3>Globus Medical P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 54.65 in the Health Care Equipment &amp; Supplies industry, Globus Medical Inc. has a lower P/E ratio of 43.78. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1750878053_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

GMED

Price Over Earnings Overview: Globus Medical

Dillard's's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDS#NYSE">DDS</a>) short percent of float has risen 7.57% since its last report. The company recently reported that it has 932 thousand shares sold short, which is 34.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Dillard's Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750878050_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Dillard's has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Dillard's's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Dillard's's peer group average for short interest as a percentage of float is 9.54%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Dillard's?

Kennametal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $22.2, a high estimate of $24.00, and a low estimate of $20.00. The current average, unchanged from the previous average price target, holds steady. 
<img src="https://www.benzinga.com/files/images/story/2025/1750878048_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Kennametal's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Dankert</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Hold</td>
<td>$24.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$24.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Angel Castillo</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Angel Castillo</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Kennametal. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Kennametal compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Kennametal's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Kennametal's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/KMT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Kennametal analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Kennametal Better</h2>
Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.
<h3>Financial Milestones: Kennametal's Journey</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Kennametal's revenue growth over a period of 3M has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -5.7%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Kennametal's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 6.47%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Kennametal's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.56%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Kennametal's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.28%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Kennametal's debt-to-equity ratio stands notably higher than the industry average, reaching 0.53. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Kennametal: 5 Analysts Share Their Views

In the latest quarter, 33 analysts provided ratings for Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">12</td>
<td align="right">6</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">8</td>
<td align="right">5</td>
<td align="right">12</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $201.33, a high estimate of $250.00, and a low estimate of $130.00. This current average has increased by 10.52% from the previous average price target of $182.16. 
<img src="https://www.benzinga.com/files/images/story/2025/1750878039_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Oracle among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$250.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$250.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Kash Rangan</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$195.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$235.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$196.00</td>
<td>$186.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$221.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$195.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$220.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$170.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$240.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$185.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Kirk Materne</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$215.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$225.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$180.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Jackson Ader</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$225.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Brad Zelnick</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$240.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Brad Sills</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$220.00</td>
<td>$156.00</td>
</tr>
<tr>
<td>Curtis Shauger</td>
<td>WestPark Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$246.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$130.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$186.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$200.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$220.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$130.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$160.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$180.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$140.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$220.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Curtis Shauger</td>
<td>WestPark Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$195.00</td>
<td>-</td>
</tr>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$190.00</td>
<td>$220.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Oracle. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Oracle compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Oracle's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Oracle's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ORCL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Oracle analyst ratings.</a>
<h2>Discovering Oracle: A Closer Look</h2>
Oracle provides enterprise applications and infrastructure offerings around the world through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used for running online transaction processing and data warehousing workloads. Besides database systems, Oracle also sells enterprise resource planning, or ERP, customer relationship management, or CRM, and human capital management, or HCM, applications. Today, Oracle has more than 159,000 full-time employees in over 170 countries.
<h3>Unraveling the Financial Story of Oracle</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Positive Revenue Trend: Examining Oracle's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 11.31% as of 31 May, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Oracle's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 21.55% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Oracle's ROE excels beyond industry benchmarks, reaching 18.43%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Oracle's ROA stands out, surpassing industry averages. With an impressive ROA of 2.08%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Oracle's debt-to-equity ratio is notably higher than the industry average. With a ratio of 5.09, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ORCL

A Glimpse Into The Expert Outlook On Oracle Through 33 Analysts

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Cheesecake Factory (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAKE#NASDAQ">CAKE</a>) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Cheesecake Factory, presenting an average target of $50.67, a high estimate of $62.00, and a low estimate of $40.00. A 0.65% drop is evident in the current average compared to the previous average price target of $51.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1750878028_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Cheesecake Factory. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Ivankoe</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$58.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>John Glass</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$40.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$50.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$49.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$46.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$62.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$46.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Cheesecake Factory. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Cheesecake Factory compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Cheesecake Factory's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Cheesecake Factory's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CAKE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cheesecake Factory analyst ratings.</a>
<h2>About Cheesecake Factory</h2>
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
<h3>Cheesecake Factory's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining Cheesecake Factory's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.04% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Cheesecake Factory's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 3.55%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Cheesecake Factory's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.42% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Cheesecake Factory's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.07%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Cheesecake Factory's debt-to-equity ratio surpasses industry norms, standing at 6.19. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CAKE

The Analyst Verdict: Cheesecake Factory In The Eyes Of 9 Experts

Throughout the last three months, 22 analysts have evaluated Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Texas Instruments and provided 12-month price targets. The average target is $183.91, accompanied by a high estimate of $225.00 and a low estimate of $125.00. A 8.42% drop is evident in the current average compared to the previous average price target of $200.81. 
<img src="https://www.benzinga.com/files/images/story/2025/1750878014_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Texas Instruments among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Buchalter</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$200.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Matthew Prisco</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$200.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$190.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Christopher Danely</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Jay Goldberg</td>
<td>Seaport Global</td>
<td>Announces</td>
<td>Sell</td>
<td>$130.00</td>
<td>-</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$170.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Cody Acree</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$200.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Timothy Arcuri</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$215.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Joseph Moore</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$148.00</td>
<td>$146.00</td>
</tr>
<tr>
<td>Matthew Prisco</td>
<td>Cantor Fitzgerald</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$170.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$195.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$171.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Joshua Buchalter</td>
<td>TD Securities</td>
<td>Maintains</td>
<td>Hold</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Brett Fishbin</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$215.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Kevin Garrigan</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$216.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$125.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Tore Svanberg</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$160.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$176.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Timothy Arcuri</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$225.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Christopher Danely</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$210.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Tristan Gerra</td>
<td>Baird</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Texas Instruments. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Texas Instruments compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Texas Instruments's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Texas Instruments's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TXN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Texas Instruments analyst ratings.</a>
<h2>Discovering Texas Instruments: A Closer Look</h2>
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
<h3>Financial Insights: Texas Instruments</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3M period, Texas Instruments showcased positive performance, achieving a revenue growth rate of 11.14% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Texas Instruments's net margin is impressive, surpassing industry averages. With a net margin of 28.98%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Texas Instruments's ROE stands out, surpassing industry averages. With an impressive ROE of 7.08%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Texas Instruments's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.4% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Texas Instruments's debt-to-equity ratio surpasses industry norms, standing at 0.78. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

22 Analysts Have This To Say About Texas Instruments

Zohran Mamdani is expected to win the New York City Democratic Primary in a <a href="https://www.benzinga.com/news/politics/25/06/46087359/zohran-mamdani-leads-nyc-mayoral-primary-andrew-cuomo-concedes-race">surprising turn of events, </a>defeating former New York Governor Andrew Cuomo.
While the win secures Mamdani a spot on the general election ballot, he still faces a tough road in November's mayoral race.
What Happened: On Tuesday night, Cuomo—backed by several billionaires during the race—quickly congratulated Mamdani on his primary victory. But he also made it clear he hasn't ruled out an independent run in the November election. 

"I said he won the primary election," Cuomo <a href="https://www.nytimes.com/2025/06/25/nyregion/nyc-mayor-election-november.html">told </a>the New York Times. "I said I wanted to look at the numbers and the ranked-choice voting to decide about what to do in the future, because I'm also on an independent line. And that's the decision, that's what I was saying."
With no candidate receiving a 50% majority on Tuesday night, voters&#8217; second-place votes will be counted in a process that eliminates candidates and continues until one remains.
Cuomo's defeat came as a surprise to many. The former governor resigned four years ago amid sexual harassment allegations, which he denied. Backed by billionaires, Cuomo also aligned more closely with the traditional Democratic establishment than Mamdani, a democratic socialist.
Mamdani, 33, has sparked widespread debate with a platform that includes freezing rent, raising taxes on the wealthy, free city bus service, universal child care, and city-owned grocery stores.
Those policies have proven unpopular with the wealthy city residents and could see money poured towards candidates to defeat Mamdani in the November election.
Read Also: <a href="https://www.benzinga.com/news/legal/25/03/44094049/cuomos-mayoral-bid-shakes-up-nyc-race-drawing-major-power-brokers-and-critics-alike">Cuomo&#8217;s Mayoral Bid Shakes Up NYC Race, Drawing Major Power Brokers And Critics Alike</a>
What Happens Next: Mamdani's potential win on Tuesday is no guarantee that he will win in November. Regardless of whether Cuomo jumps in as an Independent, Mamdani will face off against incumbent mayor Eric Adams.
Adams is a Democrat who has been at odds with his party and is choosing to run in the November election as an Independent.
Some Democrats are hoping that Cuomo doesn't run in the general election, as his inclusion could split votes between Cuomo and Adams and secure a path for Mamdani to win the election. The large majority of Democratic voters, who outnumber the Republicans six-to-one, according to the New York Times, could split the vote between multiple candidates.
Another potential option could be a third-party run by someone like Andrew Yang, who previously ran in the New York City mayoral race in 2021 and ran for president in the 2020 election.
Yang established the Forward Party and, according to The Hill, reached out to billionaire Elon Musk as recently as this month to collaborate on a third party.
"We have been of the opinion that America needed a new political party for a number of years," Yang told <a href="https://www.politico.com/news/magazine/2025/06/07/elon-musk-third-party-andrew-yang-interview-00392288">Politico </a>in an interview.
Yang reached out to Musk at a time when Musk was feuding with President Donald Trump and even polled his X followers to see if a third party that represents those who identify in the middle politically should be launched. Over 5.6 million people voted in the <a href="https://x.com/elonmusk/status/1930685402631053403" target="_blank" rel="noopener">poll,</a><a href="https://x.com/elonmusk/status/1930685402631053403"> </a>with 80.4% saying yes, although not all the votes were likely from eligible American voters.
Yang has been supportive of Musk and the potential of a third party, which comes after Musk spent hundreds of millions to help support Trump in the 2024 presidential election.
"I want to work with people that recognize that America's political system has gone from dysfunctional to polarizing to even worse. And at this point, the fastest growing political movement in the United States is independents."
Yang highlighted that Musk has supported candidates that are both Democratic and Republican in the past and like other voters who supported Trump and the "Make America Great Again" movement, could be looking for alternatives going forward.
On Wednesday, Yang <a href="https://x.com/AndrewYang/status/1937858506704539894">tweeted </a>that &#8220;it&#8217;s a new day,&#8221; while sharing several posts about the NYC mayoral race.
While Yang or Cuomo will not necessarily run in the New York City mayoral race, a broader field of independent candidates could split the vote, making this one of the most consequential tests of whether a third party can win a major race.
Current odds on prediction market <a href="https://polymarket.com/event/new-york-city-mayoral-election">Polymarket </a>show Mamdani as the favorite to win the November election at 73.1%, followed by Adams at 22.0%. Cuomo is listed with a current 2.9% chance, but that comes without him declaring an Independent run. Yang is listed with less than a 1% chance of winning, without publicly entering the race.
Another Polymarket prediction market is for whether Cuomo will run as a non-Democrat in the general election, with yes getting 34% of the vote.
On <a href="https://kalshi.com/?live=new-york-city-mayor-election">Kalshi</a>, Mamdani is the favorite at 73%, followed by Adams and 24% and Cuomo at 5%. Yang is not currently listed.
Mamdani's primary win could impact stocks with a heavy presence in New York. Here are several movers <a href="https://x.com/SaraEisen/status/1937905974960062625">highlighted </a>by CNBC's Sara Eisen.
Flagstar Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) is down 5% to $10.63 on Wednesday.
SL Green Realty Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>) is down 5% to $58.63 on Wednesday.
Vornado Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNO#NYSE">VNO</a>) is down 6% to $36.23 on Wednesday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/45807476/mark-cuban-check-marks-elon-musks-idea-of-a-new-political-party-that-represents-the-middle">Mark Cuban Check Marks Elon Musk&#8217;s Idea Of A New Political Party That Represents &#8216;The Middle&#8217;</a></li>
</ul>
Photo: Ron Adar / Shutterstock.com

Politics

Movers

Democratic Party Implodes As MAGA Revolts — Can Musk, Yang Build Third Party?

<a href="https://x.com/BitcoinMagazine/status/1937944775820468637">https://x.com/BitcoinMagazine/status/1937944775820468637</a>

$BTC

Bitcoin Magazine Posts On X "White House Deputy Director said there is an 'accumulation plan' for the US to buy more Bitcoin"

Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) on Wednesday announced<a href="https://www.globenewswire.com/news-release/2025/06/25/3104985/0/en/Biogen-to-Advance-Investigational-Spinal-Muscular-Atrophy-Asset-to-Registrational-Studies-Based-on-Positive-Interim-Phase-1-Results.html"> in</a> a press release the topline results from the Phase 1 study of salanersen (BIIB115/ION306), an antisense oligonucleotide (ASO) being developed for <a href="https://www.benzinga.com/general/biotech" target="_blank" rel="noreferrer noopener">spinal muscular atrophy (SMA)</a>.
Biogen licensed the global development, manufacturing and commercialization rights for salanersen from Ionis Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>). Salanersen was discovered by Ionis.
Leveraging the same mechanism of action as Spinraza (nusinersen) but designed to achieve greater potency, salanersen can achieve high efficacy and enable once-a-year dose.
Also Read: <a target="_blank" href="https://www.benzinga.com/m-a/25/06/45949485/supernus-pharma-acquires-maker-of-postpartum-depression-drug-zurzuvae-in-795-million-deal" rel="noreferrer noopener">Supernus Pharma Acquires Maker Of Postpartum Depression Drug Zurzuvae In $795 Million Deal</a>
An interim analysis of the phase one study in participants with SMA who were previously treated with Novartis AG&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) gene therapy, Zolgensma (onasemnogene abeparvovec), was conducted to inform the decision on whether to move salanersen forward <a href="https://www.benzinga.com/pressreleases/25/06/g46091748/biogen-to-advance-investigational-spinal-muscular-atrophy-asset-to-registrational-studies-based-on" target="_blank" rel="noreferrer noopener">into registrational studies</a>.
Both dose levels tested, 40 mg and 80 mg, given once a year, were generally well-tolerated and led to substantial slowing of neurodegeneration, as shown by reductions in neurofilament.
Exploratory clinical outcome data show clinically meaningful improvements in function and attainment of new World Health Organization (WHO) milestones over one year.
Interim results are from part B (n=24) in individuals who received either 40 mg or 80 mg salanersen once a year.
In participants with elevated baseline concentrations of neurofilament light chain (NfL), indicating ongoing neurodegeneration, initiation of salanersen led to mean reductions in NfL of 70% at six months, which were sustained through the one-year dosing interval.
Exploratory clinical outcome data were evaluated for the subgroup of participants with at least one year of follow-up during the interim analysis (n=8 participants aged 2-12 who received 40 mg of salanersen). Half (four out of eight) of these participants achieved new WHO motor milestones they could not previously achieve on their own or required assistance, such as walking, crawling, standing or sitting.
Furthermore, these participants experienced clinically meaningful improvements in motor function from baseline to one year, including a 3.3-point (SD 4.46) mean improvement from baseline on the Hammersmith Functional Motor Scale – Expanded (HFMSE) and a 5.3 point (SD 4.75) improvement on the Revised Upper Limb Module (RULM).
Biogen is currently engaging with global health authorities regarding the design of the phase 3 studies.
Earlier in June, Biogen initiated dosing in the BRAVE phase 3 study to evaluate the efficacy and safety of omaveloxolone in children with Friedreich ataxia (FA) between <a href="https://www.benzinga.com/pressreleases/25/06/g45992415/biogen-initiates-phase-3-pediatric-study-of-omaveloxolone-for-the-treatment-of-friedreich-ataxia" target="_blank" rel="noreferrer noopener">the ages of 2 to &lt;16</a>.
Both non-ambulatory and ambulatory participants may qualify for the study.
Currently, omaveloxolone is commercialized under the brand name Skyclarys in over 40 countries, including the U.S. and the European Union, and is the only approved product for FA in adults and adolescents aged 16 years and older.
BIIB Price Action: Biogen stock is up 0.58% at $127.04 at publication on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46097512/robotaxi-roll-out-tesla-uber-and-waymo-take-diverging-roads-to-autonomy" target="_blank" rel="noreferrer noopener">Robotaxi Roll Out: Tesla, Uber And Waymo Take Diverging Roads To Autonomy</a></li>
</ul>
Photo: New Africa via Shutterstock

Biotech

Large Cap

Health Care

BIIB

IONS

Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma

WIIM

ONDS

ONDS stock has given up its prior gain. Ondas Holdings shares were trading higher after announcing a partnership with Detroit Manufacturing Systems to boost U.S. drone production.

Although glucagon-like peptide-1 (GLP-1) agonists have shown promising results in reducing weight and cardiovascular risks, new data reveals that many U.S. adults struggle to stay on <a target="_blank" href="https://www.benzinga.com/topic/weight-loss" rel="noreferrer noopener">long-term treatment</a>.
While newer obesity-indicated GLP-1 therapies, such as semaglutide and tirzepatide, are increasingly used, poor persistence rates threaten the clinical and economic benefits of these medications.
Novo Nordisk A/S' (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) semaglutide is the main input in Ozempic and Wegovy, and tirzepatide is a key ingredient in Eli Lilly &amp; Co's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Mounjaro and Zepbound.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/46076029/novos-india-move-could-reshape-the-weight-loss-drug-war-with-eli-lilly" rel="noreferrer noopener">Novo's India Move Could Reshape The Weight-Loss Drug War With Eli Lilly</a>
GLP-1 agonists have been linked to 10% to 20% weight loss in clinical trials, with some studies also showing reduced cardiovascular events in individuals without diabetes.
Yet, despite these benefits, long-term adherence remains a major hurdle. A 2023 real-world study by Prime Therapeutics found that just 27% of users remained adherent for one year, and only 15% persisted for two years. At three years, only 8.1% of users were still on treatment.
Even the best-performing drug, Wegovy, had a three-year persistence rate of just 14.3%.
The three-year analysis included 5,780 individuals continuously enrolled in a health plan after initiating GLP-1 treatment for obesity.
The group had a mean age of 46.7 years, and nearly 80% were women. Persistence rates varied widely by medication, from 14.3% with weekly semaglutide (Wegovy) to 2.5% with daily liraglutide (Victoza).
Over three years, only 12.5% of users met the standard for adherence based on medication possession, and more than one-third switched to a different GLP-1 therapy.
However, more recent <a target="_blank" href="https://www.primetherapeutics.com/w/prime-therapeutics-leading-research-shows-only-1-in-12-remain-on-a-glp-1-drug-for-obesity-at-three-years" rel="noreferrer noopener">data</a> suggests that persistence may be improving. In a separate year-over-year analysis involving 23,025 individuals initiating high-potency GLP-1s—Wegovy and Zepbound—one-year persistence rose from 33.2% in 2021 to 62.7% in 2024.
Tirzepatide (Zepbound), introduced in late 2023, had one-year persistence rates of over 62% in both 2023 and 2024.
This trend toward better short-term adherence is attributed to reduced supply shortages, improved dose escalation strategies, better side-effect management, and support programs.
Nonetheless, experts <a target="_blank" href="https://www.primetherapeutics.com/documents/d/primetherapeutics/prime-therapeutics_glp-1-therapy-to-treat-obesity-among-members-without-diabetes_three-year-persistence" rel="noreferrer noopener">caution</a> that poor long-term persistence among early adopters signals potential investment risk and limits the therapies' full clinical impact.
Further research is needed to understand why so many users discontinue treatment and whether newer approaches can sustain adherence over the long term.
Price Action: LLY stock is up 1.92% at $792.37, and NVO stock is down 5.03% at $67.17 at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/fda/25/06/46101643/did-the-fda-make-a-mistake-sareptas-elevidys-approval-under-scrutiny">Did The FDA Make A Mistake? Sarepta&#8217;s Elevidys Approval Under Scrutiny</a></li>
</ul>
Photo by Tobias Arhelger via Shutterstock

US Adults Struggle With Long-Term Use Of Obesity Drugs Like Wegovy, Data Shows

<a href="https://www.cnbc.com/2025/06/25/nvidia-shareholder-meeting-2025-robots.html">https://www.cnbc.com/2025/06/25/nvidia-shareholder-meeting-2025-robots.html</a>

'Nvidia CEO says robotics is chipmaker's biggest opportunity after AI'- CNBC

Despite recent volatility, long-term holders of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), and XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) are enjoying substantial gains — a payoff for their patience <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45335892/decade-old-bitcoin-whale-emerges-transfers-207-51-million-btc-with-nearly-112000-profit">during earlier market cycles.</a>
What Happened: According to new <a href="https://x.com/santimentfeed/status/1937569460896092327">data</a> from Santiment, 94.5% of Bitcoin's circulating supply is currently in profit, followed by Ethereum at 88.7%, reflecting strong investor conviction. 
XRP (65.1%), Dogecoin at 64.7%, and Chainlink (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/link/usd">LINK</a>) at 59.4% also show solid profitability, though these levels suggest a more balanced sentiment between caution and optimism.
Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>), however, lags with only 46.5% of its supply in profit, indicating that a majority of holders are underwater. 
While this signals bearish sentiment among investors who bought near previous highs, it could also represent a potential value opportunity if bullish momentum returns in the second half of 2025. 
This implies undervaluation and more of a bearish sentiment from jaded investors who bought at a higher price than where ADA sits currently.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46101110/bitcoin-senator-cynthia-lummis-lauds-white-houses-real-enthusiasm-for-crypto-legislation">&#8216;Bitcoin Senator&#8217; Cynthia Lummis Lauds White House&#8217;s &#8216;Real Enthusiasm&#8217; For Crypto Legislation</a>
Why It Matters: High profitability levels often signal strong market confidence, but they can also precede profit-taking corrections, particularly when fear and greed rapidly alternate. 
Santiment <a href="https://x.com/santimentfeed/status/1937892738684576217">observed</a> that Bitcoin has recently climbed back to $108,200, buoyed by positive reaction to the ceasefire between Israel and Iran, which remains intact.
Meanwhile, Chainlink's 11% surge today <a href="https://x.com/santimentfeed/status/1937601918819336673">came</a> as the number of LINK holders hit a record 769,380. 
Despite this, active wallets over the past year are down 17.3%, signalling a shift toward long-term accumulation.
Ethereum's outlook also remains optimistic, with trader Ted Pillows <a href="https://x.com/TedPillows/status/1937829374134247475">noting </a>that whales are positioning long, suggesting bullish expectations into year-end.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46091840/bitcoin-ethereum-xrp-dogecoin-hold-gains">Bitcoin, Ethereum, XRP, Dogecoin Hold Gains As Crypto ETF Inflows Continue</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$DOGE

$ETH

$LINK

$XRP

Bitcoin, Ethereum, XRP Holders Sitting On Profits, While Dogecoin Trails: Report

Shares of Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) are trading higher Wednesday, adding to gains of more than 25% over the past month. Here&#8217;s a look at <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46080942/why-amd-stock-is-soaring-tuesday">what&#8217;s going on</a>.
What To Know: AMD shares are rallying this week after the chipmaker announced a new collaboration with HCLTech aimed at accelerating enterprise digital transformation. The two companies plan to establish joint innovation labs focused on developing solutions in AI, digital infrastructure and cloud computing.
AMD CEO Lisa Su said the partnership will help deliver cutting-edge technology to give businesses the solutions they need to accelerate innovation. 
&#8220;Combining HCLTech&#8217;s expertise in digital transformation with our industry-leading EPYC, Instinct and Ryzen PRO processors will enable us to provide enterprises with customized, future-ready solutions that maximize the potential of AI, cloud computing and advanced analytics,&#8221; Su said.
Semiconductor stocks have seen strong momentum in recent trading sessions following easing tensions in the Middle East. AMD also got a boost this week after Melius Research analyst Ben Reitzes upgraded AMD from Hold to Buy and raised the price target from $110 to $175, reflecting growing confidence in the company&#8217;s positioning in the AI and enterprise computing space.
Earlier this month, multiple analysts came out with <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45955190/amd-stock-is-soaring-monday-whats-going-on">positive updates</a> after AMD unveiled multiple new products at its "Advancing AI"  event. Piper Sandler raised its target to $140 and reiterated an Overweight rating. Roth Capital and Evercore ISI also lifted their targets to $150 and $144, respectively, while Rosenblatt recently maintained a Buy rating with a $200 target.
Is AMD A Good Stock To Buy?
Wall Street analysts view AMD on the whole as a Outperform, given the history of coverage over the past three months. 
But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past three months, AMD rose 35.59%, which indicates that opinion improved on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which rose 35.9% over the past year.
AMD Price Action: AMD shares were up 3.17% at $142.82 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46099022/best-ai-stocks-nvidia-semiconductors-top-performers">The AI Rally Just Flipped—These Stocks Are Now Outgunning Nvidia</a></li>
</ul>
Image via Shutterstock.

What's Going On With AMD Shares Today?

H.C. Wainwright analyst Heiko F. Ihle reiterated a Buy rating on U.S. Gold Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAU#NASDAQ">USAU</a>) <a href="https://www.benzinga.com/quote/USAU/analyst-ratings" target="_blank" rel="noreferrer noopener">with a price forecast of $15</a>.
Ihle highlighted that U.S. Gold Corp. released key details on its upcoming Feasibility Study, or FS on June 24, following the updated Pre-Feasibility Study published in February 2025.
The analyst noted that the FS will include a site-specific Association for Advancement of Cost Engineering (AACE) Class 3 cost estimate and a detailed execution plan aimed at aligning with the current project timeline.
Also Read: <a href="https://www.benzinga.com/markets/commodities/25/04/44754594/gold-miners-rally-as-bullion-hits-3212-record-trump-tariffs-fuel-over-20-year-to-date-surge-across-sector" target="_blank" rel="noreferrer noopener">Gold Miners Rally As Bullion Hits $3,212: Trump Tariffs Fuel Over 20% Year-To-Date Surge Across Sector</a>
The FS is expected to be finalized by the fourth quarter, and he writes it will outline a practical and appealing path forward for the fully permitted CK Gold Project.
This apart, Ihle stated that his valuation of U.S. Gold Corp. is based on a discounted cash flow (DCF) model for the CK Gold Project, using a 15% discount rate, consistent with other early-stage mining projects in top-tier jurisdictions.
His DCF model yields a value of $206.9 million, or $11.69 per share, for the CK asset. He assigns an additional $50 million combined value for the Challis ($28 million), Keystone ($20 million), and Orevada ($2 million) projects.
Ihle also noted that these non-core asset estimates appear increasingly conservative given current spot gold prices of $3,325 per ounce.
Ihle highlighted that a recent $7.3 million cash boost from exercised warrants should support near-term operational needs as the company works toward future milestones.
The analyst emphasized that U.S. Gold remains well-positioned to drive long-term shareholder value, especially amid favorable gold prices and recent progress.
He further highlighted the company&#8217;s impending inclusion in the Russell 3000 and Russell 2000 indexes, effective June 30, 2025. This move is poised to significantly increase trading volume as index funds adjust their portfolios to include the stock.
Price Action: USAU shares are trading lower by 1.76% to $12.60 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46096528/nasdaq-100-record-highs-rally-historical-performance" target="_blank" rel="noreferrer noopener">Nasdaq 100 Hits Record Highs After 30% Rally: History Suggests It&#8217;s Not Done Yet</a></li>
</ul>
Photo via Shutterstock

Equities

Price Target

Reiteration

USAU

U.S. Gold Is Fortified By Assets, $7.3 Million Boost, And Soaring Gold: Analyst

<a href="https://www.bloomberg.com/news/articles/2025-06-25/russia-is-open-to-new-output-hike-if-opec-decides-it-s-needed">https://www.bloomberg.com/news/articles/2025-06-25/russia-is-open-to-new-output-hike-if-opec-decides-it-s-needed</a>

'Russia Is Open to New Output Hike If OPEC+ Decides It's Needed'- Bloomberg

Surf Air Mobility Inc.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) (the "Company"), a leading regional air mobility platform, announced today that it has entered into definitive agreements for the purchase and sale of 10,800,002 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $2.50 per share (or pre-funded warrant in lieu thereof) in a registered direct offering. The offering is expected to close on or about June 26, 2025, subject to the satisfaction of customary closing conditions.
The gross proceeds to the Company from the offering are expected to be approximately $27 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds from the offering to pay down certain indebtedness and for general corporate purposes. &nbsp;

Offerings

SRFM

Surf Air Mobility Announces $27M Registered Direct Offering At $2.50/Shr

Press Releases

ASIAN MANUFACTURING ACTIVITY FALLS TO 17-MONTH LOW AS TARIFFS HIT CHINA-BASED SUPPLIERS: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Anomali Appoints George Moser as Chief Growth Officer

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index

APi Group Set to Join S&P MidCap 400

Commodities

Canadian Oil Sands Production Expected to Reach All-time Highs this Year Despite Lower Oil Prices

Fintech

S&P Global Expands Private Markets Offering With Private Credit Identifiers Using LoanX IDs

S&P CORELOGIC CASE-SHILLER INDEX RECORDS 2.7% ANNUAL GAIN IN APRIL 2025

Dividends

S&P Global Declares Third Quarter Dividend

S&P 500 Q1 2025 Buybacks Set Quarterly Record at $293 Billion, Up 20.6%, Helping EPS Growth; Impact and Expenditures Expected to Decline in Q2 2025

S&P Global Market Intelligence Unveils GenAI-Powered Enhancements to Capital IQ Pro and Expands Insights in Private Markets and Energy Transition

NPSCY

TSX:CXB

TSX:EQX

TYO:5401

AGM Group Holdings Inc. - Class A Ordinary Shares

AGM Group Holdings

Aether Holdings

Bakkt Holdings, Inc. Class A Common Stock

Bakkt Hldgs

CME Group

Coincheck Group

Coinbase Global, Inc. - Class A Common Stock

Coinbase Global

Donnelley Financial Solutions, Inc. Common Stock

Donnelley Financial Solns

FactSet Research Systems Inc. Common Stock

FactSet Research Systems

Intercontinental Exchange Inc. Common Stock

Intercontinental Exchange

Open Lending

Moodys

Marketwise

MarketAxess Holdings, Inc. - Common Stock

MarketAxess Holdings

Morningstar

MSCI

Nasdaq

Powell Max Limited - Class A Ordinary Shares

Powell Max

Tradeweb Markets Inc. - Class A Common Stock

Tradeweb Markets

Value Line

Stifel

Wells Fargo

Baird

JP Morgan

골드만삭스 리서치가 새로운 해를 맞아 대담한 주식 선택과 2025년 <a href="https://www.benzinga.com/general/biotech/24/12/42710358/veteran-investor-bets-big-on-sp-500-hitting-7000-by-end-of-2025-these-sectors-could-lead-the-charge" target="_blank" rel="noopener">시장을 형성할</a> 다섯 가지 투자 테마를 조명했다.
무슨 일이 있었나: 목요일에 공유된 노트에서, 스티븐 크론(Steven Kron)이 이끄는 애널리스트 팀은 &#8220;컨빅션 리스트(Conviction List)&#8221; &#8211; 주목할 만한 투자 아이디어로 구성된 포트폴리오를 재조정했다.
골드만삭스는 벨덴(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>), 노르웨이 크루즈 라인 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>), 그리고 우버 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>)를 리스트에 추가했다. 이 회사들은 폭스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>), 파커 하니핀(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) 그리고 TPG(TPG.)를 대체했다.
중요성: 산업 기술이 다시 유행하고 있다. 애널리스트 마크 델라니(Mark Delaney)는 벨덴이 산업의 순환적 회복을 타고 상승하고, 고마진 소프트웨어 솔루션 비즈니스를 확장하고 있다고 보고 있다. 델라니는 2025년과 2026년 모두 컨센서스 예상치를 상회하는 주당순이익(EPS)을 예측하여, 이를 산업 분야에서 두드러진 선택으로 만들었다.
크루즈 산업은 더 강력한 2025년을 향해 항해하고 있다. 애널리스트 리지 도브(Lizzie Dove)는 순 구매 의향(NPI) 데이터의 가속화와 2023년 경영진 인사로 인한 비용 절감을 언급했다. 도브는 이 기업이 단위당 수익과 비용 격차를 2.5%포인트 확대하여 동종업계인 로얄 캐리비안 크루즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>)에 가까운 평가로 만들어질 것이라고 예상한다.
애널리스트 에릭 셰리던(Eric Sheridan)은 이동성 사업에 대한 회의론과 자율주행차의 부상에도 불구하고 우버에 대해 긍정적인 전망을 유지하고 있다. 그는 2023년에서 2026년까지 조정된 EBITDA의 연평균 성장률(CAGR)이 39%에 이를 것이라고 예측한다. 이 투자은행에 따르면, 우버는 2026년까지 $3.50의 GAAP EPS를 제공할 것으로 예상되며, 이는 컨센서스보다 7% 높은 수치이다. 골드만삭스는 우버 주식에 대해 12개월 목표 주가를 $96로 설정하여, 현재 시장 수준에서 거의 60% 상승할 것으로 예상한다.
<h3 class="wp-block-heading">2025년에 주목할 주요 테마: AI, M&amp;A, 탈세계화 등</h3>
이 투자은행은 새해를 맞이하여 주목해야 할 다섯 가지 주요 테마를 제시했습니다.
<ul>
<li>인공지능(AI): 골드만삭스의 카시 랑간(Kash Rangan)은 AI 투자가 2025년에 인프라 지출에서 플랫폼과 애플리케이션으로 전환될 것이라고 예상한다. 최근 노트에서 랑간은 AI가 기업 소프트웨어에 점점 더 통합되고 있음을 강조했다. 이 트렌드에 노출된 주식으로는 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), 스노우플레이크(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) 그리고 테라다인(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>)이 있다.</li>
</ul>
<ul>
<li>규제 완화, M&amp;A, 자본 시장 회복: 잠재적인 트럼프 행정부 2기 아래의 규제 변화가 M&amp;A 활동을 가속화할 수 있다고 골드만의 애널리스트들이 말한다. 씨티그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), 에버코어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>) 그리고 S&amp;P 글로벌(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>)과 같은 금융 기업들이 혜택을 볼 수 있다. 애널리스트 리차드 램스덴(Richard Ramsden)은 최근 은행과 금융 자문사에 대한 환경이 더 유리해질 것이라고 언급했다.</li>
</ul>
<ul>
<li>미국 재충전: 칼리 데이븐포트(Carly Davenport)는 데이터 센터와 AI 컴퓨팅의 전력 수요 증가를 강조하며, 이 추세가 유틸리티 자본 지출의 지속적인 성장을 주도하고 있다고 지적했다. 그녀의 팀은 운송 전기화를 지원하기 위한 에너지 인프라의 중요성을 강조했다. DBA 셈프라(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>)가 골드만의 이 분야 최고의 선택이다.</li>
</ul>
<ul>
<li>탈세계화: 관세 전쟁의 시대는 끝나지 않았다. 얀 하치우스(Jan Hatzius)와 경제팀은 중국 수입품에 대한 관세가 20%포인트 인상되고, 유럽 자동차와 멕시코 전기차에 새로운 세금이 부과될 것으로 예상한다. 벌컨 머티리얼즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>)와 우드워드(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>)와 같은 회사들은 이러한 정책으로 인한 공급망 혼란에 잘 적응할 수 있다.</li>
</ul>
<ul>
<li>탄력적인 미국 소비자: 거시적 우려에도 불구하고 골드만삭스는 미국 소비자들에게 또 다른 강력한 해를 그리고 있다. 재량적 현금 흐름이 2025년에 5.2% 증가할 것으로 예상되며, 2024년의 4.4%에서 상승할 것으로 보인다. 이는 저축률 상승에 의해 지원된다. 주목해야 할 주식으로는 노르웨이 크루즈 라인, 우버, 벌링턴 스토어스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) 그리고 핀터레스트(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>)가 있다.</li>
<li></li>
</ul>
지금 읽어보세요:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/01/42770597/wall-street-watches-january-sp-500-tends-to-gain-yet-streaming-giant-steals-the-market-show">월스트리트가 1월을 주목 &#8211; S&amp;P 500은 상승하는 경향이 있지만, 스트리밍 대기업이 시장의 관심을 빼앗습니다.</a></li>
</ul>
이미지: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

골드만삭스, '컨빅션 리스트'에 3개의 주식 추가 및 2025년 주목해야 할 5가지 시장 동향

최근 미국 증권거래위원회(SEC)는 무디스(NYSE:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/mco" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for MCO">MCO</a>)의 무디스 레이팅스(Moody&#8217;s Ratings), S&amp;P 글로벌(NYSE:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/spgi" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for SPGI">SPGI</a>)의 S&amp;P 글로벌 레이팅스, 피치 레이팅스(Fitch Ratings, Inc.)를 포함한 6개의 주요 신용평가사들에 대해 전자 통신의 유지 및 보존에 중대한 결함이 있었다며 막대한 벌금을 부과했다. 이들 기관들은 총 4,900만 달러를 초과하는 민사 벌금을 납부하기로 합의했다.
무슨 일이 (What Happened): 화요일에 발표된 SEC 보도자료에 따르면, 이들 6개의 신용평가사는 각각의 SEC 명령에서 자세히 설명된 사실을 인정하고, 그들의 행위가 연방법의 기록 유지 조항을 위반했음을 인정했다. 이들 회사는 이러한 위반 사항을 시정하기 위해 준수 정책 및 절차를 강화하기 위한 조치를 취했다.
이 중 무디스와 S&amp;P 글로벌 레이팅스는 각각 2,000만 달러의 민사 벌금을 납부하기로 합의했으며, 피치 레이팅스는 800만 달러의 민사 벌금을 납부하기로 했다. 나머지 3개 회사인 HR Ratings de México, S.A. de C.V., A.M. Best Rating Services, Inc., 및 Demotech, Inc.는 각각 25만 달러, 100만 달러, 10만 달러의 벌금을 납부하기로 합의했다.
&#8220;필수 기록을 유지하고 보존하지 못하는 경우, 직원들이 회사가 의무를 준수하고 있는지 확인하는 데 어려움을 겪고, 위반한 회사에 책임을 물을 수 없게 되어 종종 투자자에게 불이익을 줄 수 있다 것을 우리는 반복적으로 목격했다&#8221;고 SEC 집행부의 부국장인 산제이 와드화(Sanjay Wadhwa)가 말했다.
이들 6개 회사는 1934년 증권거래법 섹션 17(a)(1) 및 그에 따른 규칙 17g-2(b)(7)을 위반한 혐의를 받았다. 재정적 처벌 외에도 각 신용평가 기관들은 이러한 조항을 다시 위반하지 않겠다는 명령과 경고를 받았다.
Benzinga의 문의에 대해, S&amp;P 글로벌, AM Best, HR Ratings는 SEC의 처벌을 인정하며 각자의 규제 의무를 준수할 것을 약속했다.
중요성 (Why It Matters): 이번 집행 조치는 SEC의 규제 준수에 대한 광범위한 단속의 일환이다. 이전에 <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40693531/sec-charges-galois-capital-with-custody-rule-violations-misleading-investors" target="_blank" rel="noopener" data-google-interstitial="false">SEC는 갈루아 캐피털(Galois Capital)</a>이 투자 자문법의 보관 규칙을 위반하고 투자자들을 오도한 혐의로 기소한 바 있다.
SEC는 이전에 마크 큐반(Mark Cuban)과 같은 억만장자 투자자들로부터 월스트리트에 초점을 맞추는 대신 소규모 투자자들을 희생시킨다는 비판을 받은 적이 있다.
Image via Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

美 SEC는 무디스, S&P 글로벌, 피치 포함 6개사들에 기록 유지 실패로 $4,900만 벌금 부가

상업용 부동산 업계는 원격 근무와 <a href="http://benzinga.com/analyst-ratings/analyst-color/24/04/38219988/economists-warn-feds-inflation-battle-could-trigger-recession-have-to-increase-the-" target="_blank" rel="noopener">인플레이션 상승</a>의 영향으로 계속해서 어려움을 겪고 있다.
이자율이 상승하고 다양한 산업 분야에서 사무실 공간을 축소하려는 광범위한 추세로 인해 이 분야는 전례 없는 규모의 빈 사무실 공간에 직면하게 되었다.
<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38273192/goldman-sachs-boasts-near-perfect-q1-results-5-analysts-zero-in-on-core-strengths" target="_blank" rel="noopener">월요일 실적 발표에서</a> 골드만삭스 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>)의 최고경영자(CEO) 데이비드 M. 솔로몬(David M. Solomon)은 인플레이션에 대한 지속적인 우려와 지정학적 긴장 고조와 함께 상업용 부동산의 열악한 상황을 미국 성장을 둔화시키는 주요 요인 중 하나로 언급했다.
이 부문은 금리를 둘러싼 추측에 특히 민감해졌다. 지난달, 연방준비제도(연준)의 금리 인하가 암시되면서 <a href="https://www.benzinga.com/real-estate/reit/24/03/37882885/10-real-estate-stocks-move-on-thursday-fed-rate-cut-possibility-sparks-rally-for-troubled-sector" target="_blank" rel="noopener">여러 주식과 펀드가 상승</a>했다. 이는 일반적으로 위험한 시장에 대한 안정성을 제공한다고 칭찬받는 부문에서는 알 수 없는 변동성을 보여주었다.
불과 며칠 후 S&amp;P 글로벌(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>)은 불안정한 상업용 부동산 시장과 관련된 위험을 기반으로 5개 지역 은행의 등급을 <a href="https://www.benzinga.com//node/37950136" target="_blank" rel="noopener">하향 조정</a>하기로 결정했다.
거대 기술 기업의 운영 변화는 부분적으로 상업용 부동산 침체를 부채질하고 있다. 코로나19 사태 이후 기술 부문에서 새로운 현상이 된 원격 또는 하이브리드 근무로의 변화로 인해 많은 기업이 필요한 것보다 더 많은 사무실 공간을 확보하게 되었다.
이는 2023년 하반기에 약간의 감소세를 보인 후 <a href="https://www.benzinga.com/markets/equities/24/01/36874447/tech-layoffs-up-over-300-month-over-month-in-january-3-companies-with-the-most-employees-laid-of" target="_blank" rel="noopener">2024년 1분기 동안 기술 부문</a>에서 계속해서 일반적인 관행으로 이어졌던 대규모 해고 추세에 추가되었다.
지난달 말 아마존닷컴 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)은 <a href="https://www.benzinga.com/news/24/03/37983953/amazons-strategic-real-estate-plan-to-reduce-vacancy-rate-and-enhance-workspace-efficiency" target="_blank" rel="noopener">사무실 공간을 줄이고 임대를 조기 종료</a>하여 13억 달러를 절감할 계획이라고 밝혔다. 이 거대 기술 기업은 2022년과 2023년에 27,000명 이상의 직원을 해고한 후 사무실 공실률이 33.8%에 달할 것으로 예상된다.
월스트리트 저널(WSJ)의 <a href="https://www.wsj.com/real-estate/commercial/big-tech-is-downsizing-work-space-in-another-blow-to-office-real-estate-67b4685c?mod=hp_featst_pos3">보도</a>에 따르면, 알파벳(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)는 실리콘밸리의 일부 사무실 공간을 서브리스하고, 메타 플랫폼(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)은 자사 사무실 공간의 계약을 줄였다. 페이스북을 소유하고 있는 이 기업은 올해 전세계적으로, <a href="https://www.benzinga.com//node/37024306">싱가포르와</a>, <a href="https://www.benzinga.com//node/34900681">런던</a> 등의 지역을 포함하여 사무실 공간을 대폭 축소하고 있다. 한편, 세일즈포스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>)는 증권거래위원회(SEC) 보고서에서 1년 전과 비교했을 때 샌프란시스코 지역의 사무실 공간을 절반만 사용하고 있다고 밝혔다.
같이 읽기: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/04/38278182/powell-delays-fed-rate-cuts-we-need-greater-confidence-in-inflation-2-year-yields-spik">파월은 왜 이자율 인하를 미루고 있는가</a>?
기술 부문의 후퇴는 법률 회사와 금융 회사를 포함한 다른 일반적인 사무실 주거 부문의 손실을 추가할 때 부동산 부문에 특히 고통스러운 것으로 입증되었다.
무디스 애널리틱스(Moody&#8217;s Analytics) 보고서에 따르면 1월까지 전국 대도시의 평균 <a href="https://www.benzinga.com/markets/equities/24/01/36542862/empty-spaces-us-office-vacancies-rise-to-highest-levels-in-four-decades" target="_blank" rel="noopener">빈 사무실 공간은 19.6%</a>로 1979년 이후 최고치를 기록했다.
요즘 몇몇 도시에서는 극도의 사무실 공실률을 보이고 있는데, 샌프란시스코의 경우 팬데믹 이전 3.6%에 불과했던 것에 비해 36.7%를 기록했다. 이러한 공백은 시애틀, 뉴욕, 오스틴 등 기술 산업과 관련된 도시에서 더욱 두드러진다. 시애틀에서는 해당 지역에서 약 45,000명의 직원이 해고된 후 <a href="https://www.benzinga.com/news/financing/24/02/37134484/seattles-office-space-dives-98-7-dip-reflects-tech-storm-hybrid-shifts" target="_blank" rel="noopener">2023년 사무실 부동산 거래가 전년 동기 대비 98.7%</a>나 감소했다.
지난주 웰스파고(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>)의 1분기 통화에서 CEO 찰스 W. 샤르프(Charles W. Scharf)는 해당 부문의 대출 수요 감소로 인해 상업용 부동산 수익이 전년도보다 7% 감소했다고 말했다.
그러나 이 임원은 주로 사무실 공간으로 구성된 이 부문이 2023년 4분기와 비교했을 때 큰 변화를 경험하지 못했다고 덧붙였다.
자산 관리 부문에서 가장 큰 규모의 부동산 ETF인 뱅가드 부동산 지수 펀드 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNQ#NYSE">VNQ</a>)는 올 초 이후로 거의 11% 하락한 수치를 기록하며, 지난 5일 동안에만 5%의 하락을 기록하고 있다.
슈왑 US REIT ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHH#NYSE">SCHH</a>)와 리얼 에스테이트 셀렉트 섹터 SPDR 펀드 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)는 매우 유사한 추이를 보이고 있다.
그러나 이 분야의 투자자들에게 이것이 모두 나쁜 소식은 아니다. 블랙스톤(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>)의 사장인 존 그레이(Jon Gray)는 최근 지금이 부동산 급락에 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37719939/is-it-time-to-buy-the-commercial-real-estate-dip-the-worlds-biggest-private-equity-" target="_blank" rel="noopener">&#8220;저가 매수&#8221;</a>할 적절한 시기가 될 수 있다고 말했다. 자산 운용사는 연준이 조만간 금리를 인하해야 할 것이라는 점을 고려하면서 상업용 부동산의 장기적인 미래에 대해 낙관하고 있다.
그런 일이 발생하면 이러한 경기 침체로 인한 새로운 개발 공급 감소와 저렴한 차입 비용이 결합되어 업계가 다시 한 번 상승할 수 있다.
이미지는 Midjourney가 제공한 인공지능을 통해 생성되었습니다.

Comments

S&P Global

뉴스

에 대한 최신 뉴스 S&P Global (NYSE:SPGI) 주식

목요일, 1월 02, 2025

목요일, 9월 05, 2024

수요일, 4월 17, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌